Gastrointestinal Symptoms and Ethanol Metabolism in Alcoholics
|
|
- Sharyl Marsh
- 5 years ago
- Views:
Transcription
1 Digestive Diseases and Sciences, Vol. 49, No. 6 (June 2004), pp ( C 2004) Gastrointestinal Symptoms and Ethanol Metabolism in Alcoholics R. J. F. LAHEIJ, PhD,* M. VERLAAN, MSc,* M. G. H. VAN OIJEN, MSc,* M. S. DE DOELDER, MSc,* C. A. J. DEJONG, MD, PhD, and J. B. M. J. JANSEN, MD, PhD* Excessive alcohol intake frequently results in gastrointestinal discomfort. It is an empirical fact that the severity of gastrointestinal discomfort induced by alcohol abuse is subject to interindividual variation. The aim of this study was to determine whether genetic polymorphism in alcohol dehydrogenase 3 (ADH3) and cytochrome P450 2E1 (CYP2E1), important first-pass enzymes in the metabolism of ethanol, predispose to the development of gastrointestinal symptoms in alcoholics. Blood samples were obtained from 92 adult alcoholics admitted for detoxification. The samples were analyzed for genetic polymorphism in ADH3 and CYP2E1 by polymerase chain reaction followed by restriction fragment length polymorphism analyses. During an interview on the first day of hospital admission, patient characteristics and gastrointestinal symptoms in the week before admission were assessed. A total of 75 of 92 alcoholics (83%) reported symptoms: 66 patients had upper gastrointestinal symptoms (72%), 70 patients had lower gastrointestinal symptoms (76%), and 59 patients reported alarming symptoms (64%). Patients with gastrointestinal symptoms less often abused beer in comparison to those without gastrointestinal symptoms (P = 0.05). The numbers of patients with the homozygous γ 1γ 1 genotype, the heterozygous γ 1γ 2 genotype, and the homozygous γ 2γ 2 genotype in ADH3 who reported gastrointestinal symptoms were 20 (83%), 34 (76%), and 15 (88%), respectively. The number of patients with the heterozygous c1c2 CYP2E1 genotype (5%) and the heterozygous DC CYP2E1 genotype (14%) was low and also unrelated to gastrointestinal symptoms. Our data suggest that the ethanol concentrations of the consumed beverages, and not interindividual variations in the activities of first-pass alcohol-metabolizing enzymes, are associated with gastrointestinal symptoms in alcoholics. KEY WORDS: ethanol; gastrointestinal symptoms; metabolism; alcohol dehydrogenase; cytochrome P450 2E1. Ethanol consumption is considered to be an important risk factor for the development of gastrointestinal discomfort and complications (1). Side effects of ethanol consumption on upper and lower gastrointestinal tract are common. However, not every alcohol consumer develops discomfort or complications. Consequently, it might be possible that Manuscript received October 2003; accepted April 14, From the *Department of Gastroenterology, University Medical Center St. Radboud, and Novadic Network for Addiction Treatment Services/Institute for Scientists Practitioners in Addiction, University of Nijmegen, Nijmegen, The Netherlands. Address for reprint requests: Robert Laheij, University Medical Center St. Radboud, Department of Gastroenterology, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands; R.Laheij@mdl.umcn.nl. susceptibility could be influenced by interindividual variations in the activities of ethanol-metabolizing enzymes (2). Ethanol is metabolized predominantly by the liver, whereas 20% of ethanol metabolism may already occur in the gastric mucosa. Ethanol is detoxified in two steps during the first passage through the liver. The speed of every step is enzyme dependent. The enzymes involved with the first step are alcohol dehydrogenase 3 (ADH3) and cytochrome P450 2E1 (CYP2E1) (3 6). A reduction in first-pass metabolism accumulates the amount of ethanol for a longer period in the body. The local alcohol toxicity is mediated by acetaldehyde on the gastric mucosa. Acetaldehyde inhibits mucosal regeneration and forms stable adducts with mucosal proteins Digestive Diseases and Sciences, Vol. 49, No. 6 (June 2004) /04/ /0 C 2004 Plenum Publishing Corporation
2 LAHEIJ ET AL. causing gastric injury and is therefore being considered as a local carcinogen in the gastrointestinal tract. Excessive alcohol abusers are known to have more chronic gastritis than moderate or non-alcohol users (10). Persons consuming excessive amounts of alcohol with the rapid metabolizing alcohol dehydrogenase genotype have a greater risk for upper gastrointestinal malignancies in comparison to persons with other genotypes (11). The rate of ethanol metabolism variability is genetic in origin and varies between racial populations. The ADH3 gene carries two alleles, ADH3*1 and ADH3*2, which differ by one amino acid, and encodes the subunits γ 1 and γ 2, respectively. The isoenzyme γ 1 γ 1 metabolizes ethanol 2.5-fold as fast as the γ 2 γ 2 isoenzyme (4). The CYP2E1 enzyme particularly contributes to ethanol metabolism in chronic alcohol consumers. Genetic polymorphisms in CYP2E1 have been demonstrated in the transcriptionregulation region (alleles c1 and c2) and in intron 6 (alleles D and C) (5). The presence of the c2 or C allele was associated with enhanced enzyme activity (5, 6). The aim of this study was to determine whether polymorphism in the genes for ADH3 and CYP2E1 is associated with the development of gastrointestinal symptoms in alcoholics. METHODS Consecutive patients were recruited between January and November 2002 at four detoxification clinics. Patients were included if they have reached the age of 18 and were ethanol dependent following DSM-IV criteria. Patients were asked to participate on the first day of admission. After written informed consent, blood samples were taken and stored in EDTA tubes at 20 C. Patients were interviewed to assess the frequency of gastrointestinal symptoms in the week before admission. The interview included inquiries on the presence of the following gastrointestinal symptoms: abdominal pain, abdominal distension, epigastric pain, heartburn, regurgitation, bloating, flatulence, nausea, dysphagia, weight loss, hematemesis, meleana, colorectal bleeding, and diarrhea. Symptoms were scored on a 4-point Likert scale: none, mild (can be ignored), moderate (cannot be ignored but does not affect lifestyle), and severe (affects lifestyle). Serological screening for Helicobacter pylori infection was performed with the Pyloriset, which was locally validated (Pyloriset test kit; Imphos, the Netherlands). The Pyloriset is a commercially available enzyme-linked immunosorbent assay that measures IgG antibodies to H. pylori infection. Furthermore, patient characteristics and ethanol consumption-related information were collected. The ethics committee of the hospital approved the study protocol. Genotyping. DNA was isolated from whole blood using the Pure Gene DNA isolation kit, and isolation was performed according to the instructions of the manufacturer (Gentra systems). The genotyping for the polymorphism in ADH3 was carried out by polymerase chain reaction (PCR) amplification according to the method of Xu et al. (7). Subsequently the PCR product was digested using the restriction enzyme SspI (PCR/RFLP). The ADH3*1 allele contains an additional restriction site for SspI, yielding fragments of 63 and 67 bp, which is not present in the ADH3*2 allele. The CYP2E1 genotypes were determined by PCR/RFLP methods as described elsewhere (8). The restriction enzymes RsaI and PstI were used to discern the c1 and c2 alleles of the 5 -flanking region, while the enzyme DraI was used to detect the D and D polymorphisms in intron 6. Analyses. We estimated that 50% of the patients with the γ 2 γ 2 slower metabolizing genotype and 80% of the patients with the γ 1 γ 1 or γ 1 γ 2 rapid metabolizing genotype would report gastrointestinal symptoms. To detect the difference of 30% with a power of 0.80, an α of 0.05 (one-sided), and taking into account the unequal distribution of ADH3 polymorphism (a ratio of 0.3), a total of 90 patients were required. Chi-square and t-test statistics were used to estimate differences in baseline characteristics among patients with and without gastrointestinal symptoms. Abdominal pain, abdominal distension, and diarrhea were classified as lower gastrointestinal symptoms; epigastric pain, heartburn, regurgitation, bloating, flatulence, and nausea, as upper gastrointestinal symptoms. Dysphagia, weight loss, hematemesis, meleana, and colorectal bleeding were classified as alarming symptoms. Logistic regression analysis was performed to study the association between polymorphism and upper gastrointestinal symptoms, lower gastrointestinal symptoms, and alarming symptoms in order to estimate an odds ratio with 95% confidence interval (CI) for these variables. Because other factors besides interindividual variations in the activities of ethanol-metabolizing enzymes might be related to the presence of gastrointestinal symptoms, we performed a multivariate regression analysis to adjust for acid secretion inhibitory therapy and H. pylori infection. Data were analyzed by SAS version 8.0. RESULTS We included 92 Caucasian patients in the study; 73 were male and the average age was 42 years. The patients reported on average a daily ethanol consumption of 200 g for more than 10 years. A total of 75 of 92 patients (83%) suffered from gastrointestinal symptoms: 66 reported upper gastrointestinal symptoms (72%), 70 reported lower gastrointestinal symptoms (76%), and 59 patients had symptoms suspiciious for a malignancy (64%) (Table 1). Thirty-seven patients reported their alarming symptoms as mild, 26 as moderate, and 3 as severe. Patients with gastrointestinal symptoms less often abused beer in comparison to those without gastrointestinal symptoms (P = 0.05). All other patient characteristics were similar between patients with and those without gastrointestinal symptoms (Table 2). Many patients (39%) were using acid-suppressive drugs to control gastrointestinal symptoms. From patients using medication to control the gastrointestinal symptoms, 31% reported complete symptom relief, while in the other 69% symptoms did not disappear. ADH3 Genotyping. In 86 of the 92 patients we were able to evaluate the ADH3 genotype. The number of patients with the homozygous γ 1γ 1 genotype, the heterozygous γ 1γ 2 genotype, and the homozygous γ 2γ Digestive Diseases and Sciences, Vol. 49, No. 6 (June 2004)
3 GI SYMPTOMS AND ETHANOL METABOLISM IN ALCOHOLICS TABLE 1. FREQUENCY OF GASTROINTESTINAL SYMPTOMS IN THE WEEK BEFORE ADMISSION Number (%) None Mild Moderate Severe Overall 17 (18) 33 (36) 36 (39) 6 (7) Upper gastrointestinal symptoms 26 (28) 39 (42) 23 (25) 4 (4) Epigastric pain 63 (68) 20 (22) 8 (9) 1 (1) Heartburn 53 (58) 22 (24) 17 (19) 0 Regurgitation 52 (57) 28 (30) 10 (11) 2 (2) Bloating 46 (50) 28 (30) 15 (16) 3 (3) Nausea 54 (59) 27 (29) 11 (12) 0 Alarm symptoms 33 (36) 37 (40) 19 (21) 3 (3) Dysphagia 71 (77) 16 (17) 3 (3) 2 (2) Weight loss 58 (63) 20 (22) 13 (14) 1 (1) Hematemesis 85 (92) 5 (5) 2 (2) 0 Meleana 75 (82) 13 (14) 4 (4) 0 Colorectal bleeding 79 (86) 11 (12) 1 (1) 1 (1) Lower gastrointestinal symptoms 22 (24) 41 (45) 26 (28) 3 (3) Abdominal pain 57 (62) 33 (36) 2 (2) 0 Abdominal distension 35 (38) 33 (36) 22 (24) 2 (2) Diarrhea 49 (53) 32 (35) 10 (11) 1 (1) genotype was 24 (30%), 45 (52%), and 17 (20%), respectively (Table 3). There were no statistical differences in the distribution of the homozygous γ 1γ 1 genotype, the heterozygous γ 1γ 2 genotype and the homozygous γ 2γ 2 genotype among patients with upper gastrointestinal symptoms, lower gastrointestinal symptoms and alarming symptoms in comparison to patients without these symptoms. Even after adjustment for H. pylori infection and acid-suppressive therapy no association was found. TABLE 3. GASTROINTESTINAL SYMPTOMS AND ADH3 POLYMORPHISM ADH3, number (%) γ 1γ 1 γ 1γ 2 γ 2γ 2 Gastrointestinal symptoms (n = 24) (n = 45) (n = 17) Any Absent 4 (24) 11 (65) 2 (12) Present 20 (29) 34 (49) 15 (22) Upper Absent 7 (28) 13 (52) 5 (20) Present 17 (29) 32 (51) 12 (20) Lower Absent 5 (23) 12 (54) 5 (23) Present 19 (30) 33 (51) 12 (19) Alarm Absent 8 (25) 21 (66) 3 (9) Present 16 (30) 24 (44) 14 (26) CYP2E1 Genotyping. In 78 of the 92 patients included we were able to evaluate CYP2E1 genotypes. The number of patients with the homozygous c1c1 genotype, the heterozygous c1c2 genotype, and the homozygous c2c2 genotype was 74 (95%), 4 (5%), and 0 (0%), respectively. The number of patients with the homozygous DD genotype, the heterozygous DC genotype, and the homozygous CC genotype was 67 (86%), 11 (14%), and 0 (0%), respectively. Despite the fact that 10 of the 11 patients (91%) with the heterozygous DC CYP2E1 genotype reported upper gastrointestinal symptoms, 9 lower gastrointestinal symptoms (82%), and 8 alarming symptoms (73%), no statistical association was found between the CYP2E1 genotype and symptom clustering. TABLE 2. PATIENT CHARACTERISTICS BY GASTROINTESTINAL SYMPTOMS Symptoms Absent Present (n = 17) (n = 75) Male/female (No.) 14/3 57/18 Mean age (years) Helicobacter pylori seropositive (%) Smoking (%) Coaddiction Opiates (%) Cocaine (%) Cannabis (%) Medication H2-RA (%) 6 8 PPI (%) 6 19 Alcohol intake (g ethanol/day) Mean addiction duration (years) Previous detoxification (%) Beverage Beer (%)* Wine (%) Liquor (%) 7 10 *P = DISCUSSION Gastrointestinal symptoms and complications associated with ethanol abuse are common. The results from this study confirm that persons abusing ethanol often have gastrointestinal symptoms; even alarming symptoms were frequently reported. Gastrointestinal symptoms were significantly related to non-beer abusers. Our study was designed to evaluate whether interindividual variations in the activities of ethanol-metabolizing enzymes were associated with gastrointestinal symptoms. However, interindividual variations in the activities of ADH3 and CYP2E1 enzymes were not associated with gastrointestinal symptoms. This finding is, however, in line with the fact that symptoms are poorly correlated with the severity of mucosal injury. Furthermore, because most patients reported persistent symptoms during acid-suppressive therapy, the impact of medical management of gastrointestinal symptoms in alcoholics on symptom improvement seems minimal. Digestive Diseases and Sciences, Vol. 49, No. 6 (June 2004) 1009
4 LAHEIJ ET AL. The only positive finding of this study was a significant negative correlation between gastrointestinal symptoms and beer drinking. This is most likely because gastrointestinal disturbances depend on the ethanol concentration of the consumed beverages and are due either to a direct effect of highly concentrated ethanol or to the activity of enzymes with a high K m for ethanol known to prevail in the upper digestive tract, such as σ -ADH (a class IV ADH), which plays no role at systemic concentrations of ethanol but could at the very high concentrations of ethanol achieved in the upper digestive tract after drinking. The role of the two enzymes we have investigated is minimal in some of the organs where the upper gastrointestinal symptoms may be generated. The principal catalyst of ethanol in the gastroesophageal area is ADH7, a class IV alcohol dehydrogenase (σ -ADH). However, so far no major polymorphisms of the ADH7 gene have been found, except for a point mutation (16). The frequency of this point mutation is very low in the Caucasian population and therefore it is probably not responsible for the development of gastrointestinal symptoms. Alcohol dehydrogenase is an important first-step enzyme in the oxidation of alcohol to acetaldehyde (4, 9). Especially, ADH3 is the most important enzyme in the oxidation of ethanol to acetaldehyde in Caucasians. However, oxidation of alcohol by the CYP2E1 enzymes is also important, especially in chronic alcohol abusers, as it is inducible up to 10-fold by consumption of alcohol. Only few patients were heterozygous for the CYP2E1 genotype. To detect a difference in frequency of genotype between patients with and those without symptoms, many more patients need to be included. However, CYP2E1 is probably not an important risk factor for gastrointestinal symptoms because few patients are heterozygous for its genotypes. Furthermore, taking into consideration that most patients in our study had been abusing alcohol for more than 10 years, there might be an enhancement of induction of increased enzyme metabolism activity after long-term alcohol intake. Several other factors may be related to the occurrence of gastrointestinal symptoms. For example, Helicobacter pylori infection leads to morphologic gastric mucosa changes which might be associated with a decrease in alcohol metabolism (12 14). It is, however, unclear whether this reflects the bioavailability of alcohol or the amount of its first-pass metabolism. In our study, however, we did not find an association between symptoms and Helicobacter pylori infection. This finding might be a consequence of the limited number of alcoholics in our study. Despite the high prevalence of gastrointestinal symptoms, it is not known whether drugs for management of dyspeptic symptoms in the general population are equally effective in alcoholics. The impact of medical management of gastrointestinal symptoms in alcoholics seems to be minimal. Most patients using drugs for upper gastrointestinal symptoms have persistent symptoms. Traditionally, patients who present with gastrointestinal discomfort are being managed with acid-suppressive medication. Acid-suppressive medication might even increase symptoms. Treatment with proton pump inhibitors increases acetyldehyde production from ethanol (15). Furthermore, previous studies have shown that H2 receptor antagonists, especially cimitidine, are associated with increased blood alcohol levels by an effect on gastric alcohol dehydrogenase activity (3). The results from this study showed that despite many of the patients using gastric acid inhibitors for their upper gastrointestinal symptoms, many failed to respond adequately. Because of the poor results with acidsuppressive therapy, other drugs or management strategies to prevent gastrointestinal discomfort should be evaluated. In conclusion, more than three-quarters of these alcoholics who had on average abused ethanol for more than 10 years reported gastrointestinal symptoms. The combination of excessive drinking and the ADH3 and CYP2E1 genotypes was not associated with gastrointestinal symptoms. ACKNOWLEDGMENTS We would like to thank T. Wijdeveldt, MD, and P. Geenen from Paschalis, K. Rijk, MD, from the Grift, and H. de Haan, MD, from Tractus for helping collect the data. REFERENCES 1. Bujanda L: The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol 95: , Dohmen K, Baraona E, Ishibashi et al.: Ethnic differences in gastric sigma-alcohol dehydrogenase activety and first-pass metabolism. Alcohol Clin Exp Res 20: , Haber PS, Gentry RT, Mak KM, Mirmiran Yazdy SAA, Greenstein RJ, Lieber CS: Methabolism of alcohol by human gastric cells: relation to first pass metabolism. Gastroenterology 111: , Bosron WF, Li TK: Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases and their relationship to alcohol metabolism and alcoholism. Hepatology 6: , Hayasashi S, Watanabe J, Kawajiri K: Genetic polymorphisms in the 5 -flanking region change transcriptional regulation of the human cytochrome P-450IIE1 gene. J Biochem 110: , Watanabe J, Hayashi S, Kawajiri K: Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5 -flanking region. J Biochem 16: , Xu YL, Carr LG, Bosron WF, Li TK, Edenberg HJ: Genotyping of human alcohol dehydrogenases at the ADH2 and ADH3 loci following DNA sequence amplification. Genomics 2: , Stephens EA, Taylor JA, Kaplan N, Yang CH, Hsieh LL, Lucier GW, Bell DA: Ethnic variation in the CYP2E1 gene: Polymorphism 1010 Digestive Diseases and Sciences, Vol. 49, No. 6 (June 2004)
5 GI SYMPTOMS AND ETHANOL METABOLISM IN ALCOHOLICS analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics 4: , Seitz HK, Poschl G: The role of gastrointestinal factors in alcohol metabolism. Alcohol Alcohol 32: , Hauge T, Persson J, Kjerstadius T: Helicobacter pylori, active chronic antral gastritis, and gastrointestinal symptoms in alcoholics. Alcohol Clin Exp Res 18: , Yokoyama A, Kato H, Yokoyama T, et al.: Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S- transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma. Carcinogenesis 23: , Lieber CS: Gastritis in the alcoholic: Relationship to gastric alcohol metabolism and Helicobacter pylori. Addict Biol 3: , Simanowski UA, Egerer G, Oneta C, et al.: Helicobacter pylori infection decreases gastric alcohol dehydrogenase activety and firstpass metabolism of ethanol in man. Digestion 59: , Lieber CS: Gastric ethanol methabolism and gastritis: Interactions with other drugs, Helicobacter pylori and antibiotic therapy. A review. Alcohol Clin Exp Res 21: , Vakevainen S, Tillonen J, Salaspuro M, Jousimies-Somer H, Nuutinen H, Farkkila M: Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetyldehyde from ethanol. Aliment Pharmacol Ther 14: , Carr LG, Zeng D, Li TK: Failure to find exon 7 polymorphism of the ADH7 gene in Chinese, Japanese, African-Americans and Caucasians. Alchol Clin Exp Res 20: , 1996 Digestive Diseases and Sciences, Vol. 49, No. 6 (June 2004) 1011
Original Policy Date
MP 2.04.38 Genetic Testing for Helicobacter pylori Treatment Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return
More informationSelection Bias in the Assessment of Gene-Environment Interaction in Case-Control Studies
American Journal of Epidemiology Copyright 2003 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 158, No. 3 Printed in U.S.A. DOI: 10.1093/aje/kwg147 Selection Bias in the
More informationHelicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationAlcohol Dehydrogenase (ADH) Isoenzymes and Aldehyde Dehydrogenase (ALDH) Activity in the Sera of Patients with Gastric Cancer
Dig Dis Sci (2008) 53:2101 2105 DOI 10.1007/s10620-007-0135-4 ORIGINAL PAPER Alcohol Dehydrogenase (ADH) Isoenzymes and Aldehyde Dehydrogenase (ALDH) Activity in the Sera of Patients with Gastric Cancer
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): November 22, 2011 Most Recent Review Date (Revised): July 22, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS
More informationHelmut K. Seitz, M.D., and Peter Becker, M.D.
Alcohol Metabolism and Cancer Risk Helmut K. Seitz, M.D., and Peter Becker, M.D. Chronic alcohol consumption increases the risk for cancer of the organs and tissues of the respiratory tract and the upper
More informationJune By: Reza Gholami
ACG/CAG guideline on Management of Dyspepsia June 2017 By: Reza Gholami DEFINITION OF DYSPEPSIA AND SCOPE OF THE GUIDELINE Dyspepsia was originally defined as any symptoms referable to the upper gastrointestinal
More informationRESEARCH COMMUNICATION
ADH-2 and ALDH-2 Genotypes, Alcohol Drinking and Risk of Stomach Cancer in Chinese Males RESEARCH COMMUNICATION Alcohol Dehydrogenase-2 and Aldehyde Dehydrogenase-2 Genotypes, Alcohol Drinking and the
More informationAssociation Between Polymorphisms of Ethanol-Metabolizing Enzymes and Susceptibility to Alcoholic Cirrhosis in a Korean Male Population
J Korean Med Sci 2001; 16: 745-50 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences Association Between Polymorphisms of Ethanol-Metabolizing Enzymes and Susceptibility to Alcoholic Cirrhosis
More informationGastrointestinal symptoms are still common in a general Western population
ORIGINAL ARTICLE Gastrointestinal are still common in a general Western population L.A.S. van Kerkhoven *, T. Eikendal, R.J.F. Laheij, M.G.H. van Oijen, J.B.M.J. Jansen Department of Gastroenterology &
More informationNon-Ulcer Dyspepsia: what is it? What can we do with these patients? Overview. Dyspepsia Definition. Functional Dyspepsia. Dyspepsia the Basics
Non-Ulcer : what is it? What can we do with these patients? Temporal Changes and Geographic Variations in Developing Peptic Ulcer Disease Gastric Cancer 1900 Eamonn M M Quigley MD FACG Alimentary Pharmabiotic
More informationPrevalence of Multiple White and Flat Elevated Lesions in Individuals Undergoing a Medical Checkup
doi: 10.2169/internalmedicine.9808-17 http://internmed.jp ORIGINAL ARTICLE Prevalence of Multiple White and Flat Elevated Lesions in Individuals Undergoing a Medical Checkup Kyoichi Adachi 1, Tomoko Mishiro
More informationA Trip Through the GI Tract: Common GI Diseases and Complaints. Jennifer Curtis, MD
A Trip Through the GI Tract: Common GI Diseases and Complaints Jennifer Curtis, MD Colon Cancer How does it develop? Most cancers arise from polyps Over time these can turn into cancer Combination of genetic
More informationINVESTIGATION OF ALCOHOL METABOLIZING ENZYME GENES IN CHINESE ALCOHOLICS WITH AVASCULAR NECROSIS OF HIP JOINT, PANCREATITIS AND CIRRHOSIS OF THE LIVER
Alcohol & Alcoholism Vol. 38, No. 5, pp. 431 436, 2003 doi:10.1093/alcalc/agg106, available online at www.alcalc.oupjournals.org INVESTIGATION OF ALCOHOL METABOLIZING ENZYME GENES IN CHINESE ALCOHOLICS
More informationP450I I E 1 Gene : Dra I. Human Cytochrome Polymorphism and
Tohoku J. Exp. Med., 1992, 168, 113-117 Human Cytochrome Polymorphism and P450I I E 1 Gene : Dra I Susceptibility to Cancer FUMIYUKI VEMATSUHIDEAKI KIKUCHI*, MASAKICHI MOTOMIYA j', TATSUYA ABE j', CHIKASHI
More informationCYP2C19-Proton Pump Inhibitors
CYP2C19-Proton Pump Inhibitors Cameron Thomas, Pharm.D. PGY2 Clinical Pharmacogenetics Resident St. Jude Children s Research Hospital February 1, 2018 Objectives: CYP2C19-PPI Implementation Review the
More informationFecal incontinence causes 196 epidemiology 8 treatment 196
Subject Index Achalasia course 93 differential diagnosis 93 esophageal dysphagia 92 95 etiology 92, 93 treatment 93 95 work-up 93 Aminosalicylates, pharmacokinetics and aging effects 36 Antibiotics diarrhea
More informationCYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study
CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study Y.L. Song 1,2, L. Wang 2, J.C. Ren 1 and Z.H. Xu 1 1 Department of Urology, Qilu Hospital, Shandong University, Jinan,
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/48400
More informationACETALDEHYDE THE MOST COMMON HUMAN CARCINOGEN
ACETALDEHYDE THE MOST COMMON HUMAN CARCINOGEN Mikko Salaspuro, prof., M.D., Ph.D., Research Unit on Acetaldehyde and Cancer University of Helsinki, Helsinki, Finland COI: Board member and stock owner of
More informationGuidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee
Guidelines for the Management of Dyspepsia and GORD Document type: Version: 3.0 Author (name): Author (designation): Validated by Prescribing Dr. G. Lipscomb Date validated October 2015 Ratified by: Date
More informationDisclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome
Gastrointestinal Motility Disorders & Irritable Bowel Syndrome None Disclosures Jasmine Zia, MD Acting Assistant Professor Division of Gastroenterology, University of Washington 6 th Asian Health Symposium
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: helicobacter_pylori_testing 01/01/2019 N/A 01/01/2020 01/01/2019 Policy Effective April 1, 2019 Description
More informationCytochrome P450 2E1 RsaI/PstI and DraI Polymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han Population in Inner Mongolia
www.springerlink.com Chin J Cancer Res 23(2): 107-111, 2011 107 Original Article Cytochrome 450 2E1 RsaI/stI and DraI olymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han opulation in Inner
More informationInfluence of interleukin-18 gene polymorphisms on acute pancreatitis susceptibility in a Chinese population
Influence of interleukin-18 gene polymorphisms on acute pancreatitis susceptibility in a Chinese population H.B. Gui 1, X.G. Du 2, Z.H. Fu 3 and X.M. Chen 1 1 Department of Emergency, The First Affiliated
More informationQUICK QUERIES. Topical Questions, Sound Answers
QUICK QUERIES Topical Questions, Sound Answers Dyspepsia: An Evidence-Based Approach Alan B. R. Thomson, MD, PhD, FRCPC, FACP, FACG Presented at the University of Alberta s Medical Grand Rounds, University
More informationManagement of dyspepsia and of Helicobacter pylori infection
Management of dyspepsia and of Helicobacter pylori infection The University of Nottingham John Atherton Wolfson Digestive Diseases Centre University of Nottingham, UK Community management of dyspepsia
More informationLack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population
Lack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population J.J. Lu, H.Q. Zhang, P. Mai, X. Ma, X. Chen, Y.X. Yang and L.P. Zhang Gansu Provincial Hospital, Donggang
More informationGASTRIC ALCOHOL DEHYDROGENASE ACTIVITY IN MAN: INFLUENCE OF GENDER, AGE, ALCOHOL CONSUMPTION AND SMOKING IN A CAUCASIAN POPULATION
Alcohol & Alcoholism Vol. 37, No. 4, pp. 388 393, 2002 GASTRIC ALCOHOL DEHYDROGENASE ACTIVITY IN MAN: INFLUENCE OF GENDER, AGE, ALCOHOL CONSUMPTION AND SMOKING IN A CAUCASIAN POPULATION ALEXANDR PARLESAK*,
More informationIL10 rs polymorphism is associated with liver cirrhosis and chronic hepatitis B
IL10 rs1800896 polymorphism is associated with liver cirrhosis and chronic hepatitis B L.N. Cao 1, S.L. Cheng 2 and W. Liu 3 1 Kidney Disease Department of Internal Medicine, Xianyang Central Hospital,
More informationDepartment of Respiratory Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China
Association of glutathione S-transferase (GST) genetic polymorphisms with treatment outcome of cisplatin-based chemotherapy for advanced non-small cell lung cancer in a Chinese population H.L. Xiao 1,
More informationGastroesophageal Reflux Disease, Paraesophageal Hernias &
530.81 553.3 & 530.00 43289, 43659 1043432842, MD Assistant Clinical Professor of Surgery, UH JABSOM Associate General Surgery Program Director Director of Minimally Invasive & Bariatric Surgery Programs
More informationDependence Syndrome (Edwards and Gross, 1976)
Genetic Research on Alcohol and Drugs: From Abstinence to Dependence Ethics of Genetics in Research May 19, 2006 Deborah Hasin, Ph.D. Columbia University New York State Psychiatric Institute Dependence
More informationBarrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI
Barrett s Esophagus Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI A 58 year-old, obese white man has had heartburn for more than 20 years. He read a magazine
More informationCHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University
CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University 1 Definition of FGID Chronic and recurrent symptoms of the gastrointestinal
More informationAssociation between IL-17A and IL-17F gene polymorphisms and risk of gastric cancer in a Chinese population
Association between IL-17A and IL-17F gene polymorphisms and risk of gastric cancer in a Chinese population W.M. Zhao 1, P. Shayimu 1, L. Liu 1, F. Fang 1 and X.L. Huang 2 1 Department of Gastrointestinal
More informationIntragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily a randomized, two-way crossover study
Aliment Pharmacol Ther 2005; 21: 963 967. doi: 10.1111/j.1365-2036.2005.02432.x Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily a randomized,
More informationFunctional Heartburn and Dyspepsia
Functional Heartburn and Dyspepsia Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina Objectives Understand the means of diagnosing functional heartburn
More informationThe Genetics of Alcohol Metabolism. Howard J. Edenberg, Ph.D.
The Genetics of Alcohol Metabolism Role of Alcohol Dehydrogenase and Aldehyde Dehydrogenase Variants Howard J. Edenberg, Ph.D. The primary enzymes involved in alcohol metabolism are alcohol dehydrogenase
More informationACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease
ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease Philip O. Katz MD 1, Lauren B. Gerson MD, MSc 2 and Marcelo F. Vela MD, MSCR 3 1 Division of Gastroenterology, Einstein
More informationGASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali
GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers
More informationThe frequencyof Cytochrome P 450 2E 1 polymorphisms in Black South Africans
Disease Markers 22 (2006) 351 354 351 IOS Press The frequencyof Cytochrome P 450 2E 1 polymorphisms in Black South Africans Paul K. Chelule a,, Rosemary J. Pegoraro b, Nceba Gqaleni a,c and Michael F.
More informationDr. LEUNG Lok Hang, Will
Direct access endoscopy booking by family physicians: evaluating a new service model and clinical predictors of positive endoscopy findings at primary care setting Dr. LEUNG Lok Hang, Will Department of
More informationTHE abuse of alcohol is the leading risk factor for disability and premature death in the world.
THE abuse of alcohol is the leading risk factor for disability and premature death in the world. Besides tobacco an other harmful agents, alcohol is the most common cause of many illnesses in our midst,
More informationInvestigating the role of polymorphisms in mir-146a, -149, and -196a2 in the development of gastric cancer
Investigating the role of polymorphisms in mir-146a, -149, and -196a2 in the development of gastric cancer Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong
More informationNational Digestive Diseases Information Clearinghouse
Gastritis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is gastritis? Gastritis is a condition in which the stomach
More informationMETA-ANALYSIS OF THE EFFECTS OF ALCOHOL DEHYDROGENASE GENOTYPE ON ALCOHOL DEPENDENCE AND ALCOHOLIC LIVER DISEASE
Alcohol & Alcoholism Vol. 32, No. 5, pp. 613-619, 1997 META-ANALYSIS OF THE EFFECTS OF ALCOHOL DEHYDROGENASE GENOTYPE ON ALCOHOL DEPENDENCE AND ALCOHOLIC LIVER DISEASE J. B. WHITFIELD Department of Clinical
More informationSUBSTANCE USE DISORDERS
Mario San Bartolomé, MD, MBA, MRO, FASAM SUBSTANCE USE DISORDERS and the GASTROINTESTINAL TRACT Mario San Bartolome, MD, MBA, MRO, FASAM Medical Director Substance Use Disorders Molina Healthcare, Inc.
More informationThe usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.
Name Gasec - 2 Gastrocaps Composition Gasec-20 Gastrocaps Each Gastrocaps contains: Omeprazole 20 mg (in the form of enteric-coated pellets) Properties, effects Proton Pump Inhibitor Omeprazole belongs
More informationPrompt Upper Endoscopy Is an Appropriate Initial Management in Uninvestigated Chinese Patients With Typical Reflux Symptoms
nature publishing group ORIGINAL CONTRIBUTIONS 1947 Prompt Upper Endoscopy Is an Appropriate Initial Management in Uninvestigated Chinese Patients With Typical Reflux Symptoms Sui Peng, MD 1, Li-Shou Xiong,
More informationDuodenal Ulcer / Duodenitis
Duodenal Ulcer / Duodenitis Endoscopy Department Patient information leaflet You will only be given this leaflet if you have been diagnosed with duodenitis and/or a duodenal ulcer. The information below
More informationOutline. Definition (s) Epidemiology Pathophysiology Management With an emphasis on recent developments
Chronic Dyspepsia Eamonn M M Quigley MD FRCP FACP MACG FRCPI Lynda K and David M Underwood Center for Digestive Disorders Houston Methodist Hospital Houston, Texas Outline Definition (s) Epidemiology Pathophysiology
More informationGenetic polymorphisms and head and neck cancer risk (Review)
INTERNATINAL JURNAL F NCLGY 32: 945-973, 2008 945 Genetic polymorphisms and head and neck cancer risk (Review) TRU HIYAMA 1, MASAHARU YSHIHARA 1, SHINJI TANAKA 2 and KAZUAKI CHAYAMA 3 1 Health Service
More informationEffective Health Care
Effective Health Care Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease Executive Summary Background Gastroesophageal reflux disease (GERD), defined as weekly heartburn
More information11/19/2012. Comparison between PPIs G CELL. Risk ratio (95% CI) Patient subgroup. gastrin. S-form of omeprazole. Acid sensitive. coated.
REGULATION OF GASTRIC ACID SECRETION Comparison between PPIs Omeprazole Lansoprazole Rabeprazole Pantoprazole Esomeprazole gastrin G CELL + Acid sensitive Yes T1/2 30-60 minutes Main elimination Enteric
More informationUniversity Medical Center at Brackenridge. Gastroenterology Clinic Worksheet
Gastroenterology Clinic Worksheet 1. GI Bleeding (occult or symptomatic) a. CBC b. Iron, Ferritin b. Medication history 2. Iron Deficiency Anemia and no evident source (if no iron deficiency consider hematological
More informationAldehyde Dehydrogenase-2 Genotype Detection in Fingernails among Non-alcoholic Northeastern Thai Population and Derived Gene Frequency
ScienceAsia 28 (2002) : 99-103 Aldehyde Dehydrogenase-2 Genotype Detection in Fingernails among Non-alcoholic Northeastern Thai Population and Derived Gene Frequency Paiboon Mongconthawornchai a, *, Somsong
More informationImpact and Predictors of Urinalysis Ordering Among General Medicine Patients
Impact and Predictors of Urinalysis Ordering Among General Medicine Patients Penny Yin, BHSc, MD PGY-3 Internal Medicine University of Toronto Supervisor: Dr. Jerome Leis. Canadian Society of Internal
More informationTitle: DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control study
Author's response to reviews Title: DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control study Authors: Bernd Frank (b.frank@dkfz.de) Heiko Müller (h.mueller@dkfz.de) Melanie
More informationThe effect of proton pump inhibitors on the gastric mucosal microenvironment
Original papers The effect of proton pump inhibitors on the gastric mucosal microenvironment Yen-Chun Peng,,, A F, Lan-Ru Huang, A, C, E, Hui-Ching Ho, C, Chi-Sen Chang, C, E, Shou-Wu Lee, E, Ching-Chang
More informationThe significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus
University of Groningen The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus IMPORTANT NOTE: You are advised to consult the publisher's
More informationUpdate on alcohol and cancer epidemiology Is the evidence getting clearer? Dr. Isabelle Romieu
Update on alcohol and cancer epidemiology Is the evidence getting clearer? Dr. Isabelle Romieu Key Facts Alcohol is the world s third largest risk factor for disease burden More than 1.9 billion adults
More information6/25/ % 20% 50% 19% Functional Dyspepsia Peptic Ulcer GERD Cancer Other
Peptic Ulcer Disease and Dyspepsia John M. Inadomi, MD Professor of Medicine UCSF Chief, Clinical Gastroenterology San Francisco General Hospital Case History 49 y/o woman complains of several months of
More informationCYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women
CYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women L. Yang, X.Y. Wang, Y.T. Li, H.L. Wang, T. Wu, B. Wang, Q. Zhao, D. Jinsihan and L.P. Zhu The Department of Mammary
More informationThe Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal Reflux Disease
Gut and Liver, Vol. 8, No. 2, March 2014, pp. 160-164 ORiginal Article The Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal
More informationAssociation between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population
Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population R. Zhao and M.F. Ying Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University,
More informationwhat s new? CONFERENCE ALCOHOL AND HEALTH Amsterdam, 23 September 2010
CONFERENCE ALCOHOL AND HEALTH Amsterdam, 23 September 2010 Alcohol drinking and cancer risk: what s new? Dr Paule LATINO-MARTEL UMR U 557 Inserm, U 1125 Inra, Cnam, Université Paris 13; CRNH-IdF, France
More informationGastrointestinal, Hepatic, and Nutritional Challenges in FA
Gastrointestinal, Hepatic, and Nutritional Challenges in FA Sarah Jane Schwarzenberg, MD Pediatric Gastroenterology, Hepatology and Nutrition June 29, 2014 GI problems in FA 5% have gastrointestinal tract
More informationEMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated
EMILOK Global (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated granules. Properties: Emilok (omeprazole) belongs to the group of proton pump inhibitors, inhibits both
More informationCOMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées
OPTIMAL THERAPY REPORT COMPUS Volume 1, Issue 5 March 2007 Current Practice Analysis Report for the Prescribing and Use of Proton Pump Inhibitors (PPIs) Supporting Informed Decisions À l appui des décisions
More informationPolicy Evaluation: Proton Pump Inhibitors (PPIs)
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationSetting The setting was primary care. The economic study was conducted in Canada.
Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment - Helicobacter pylori positive (CADET-Hp) randomised controlled
More informationHealth-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia
Aliment Pharmacol Ther 23; 17: 835 84. doi: 1.146/j.269-2813.23.1497.x Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia A. QUADRI & N. VAKIL University of Wisconsin
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA o Patients of any age with ALARM signs should be referred through the 2-week referral system o Routine endoscopic investigation
More informationModule 2 Heartburn Glossary
Absorption Antacids Antibiotic Module 2 Heartburn Glossary Barrett s oesophagus Bloating Body mass index Burping Chief cells Colon Digestion Endoscopy Enteroendocrine cells Epiglottis Epithelium Absorption
More informationCase Report Features of the Atrophic Corpus Mucosa in Three Cases of Autoimmune Gastritis Revealed by Magnifying Endoscopy
Volume 2012, Article ID 368160, 4 pages doi:10.1155/2012/368160 Case Report Features of the Atrophic Corpus Mucosa in Three Cases of Autoimmune Gastritis Revealed by Magnifying Endoscopy Kazuyoshi Yagi,
More informationOptimal Management of GERD with Dexlansoprazole - Extended plasma concentration and dosing flexibility with a dual delayed release PPI
Optimal Management of GERD with Dexlansoprazole - Extended plasma concentration and dosing flexibility with a dual delayed release PPI Jun Heng Lee, M.D. Samsung Medical Center, Sungkyunkwan University
More informationPEPTIC ULCER DISEASE JOHN R SALTZMAN, MD. Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School
PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School No disclosures Disclosures Overview Causes of peptic ulcer disease
More informationTable 2.9. Case control studies of helicobacter pylori infection and oesophageal adenocarcinoma
Characteristics of Characteristics of controls Detection Chow et al (1998) 1993-1995 129 of newly diagnosed oesophageal/gastric cardia (OGC) adenocarcinoma. 224 population controls selected by random digit
More informationRisk Factors and Preventive Measures for Hepatocellular carcinoma (HCC) 울산의대울산대병원소화기내과박능화
Risk Factors and Preventive Measures for Hepatocellular carcinoma (HCC) 울산의대울산대병원소화기내과박능화 Risk factors for HCC development (I) Environmental factors Infectious HBV HCV HDV Alimentary Alcohol Diet High
More informationGut microbiota: importance
Gut microbiota: importance Gut microbiota: importance BACTERIA IN THE GUT SYNTHESIZE SEVERAL HUNDRED GRAMS OF ESSENTIAL AMINO-ACIDS EVERY DAY PROKARYOTES (Bacteria) capability to synthesize essential compounds
More informationPeptic ulcer disease Disorders of the esophagus
Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Burning epigastric pain Exacerbated by fasting Improved with meals Ulcer: disruption of mucosal integrity >5 mm in size, with depth
More informationGenetics and Genomics: Influence on Individualization of Medication Regimes
Genetics and Genomics: Influence on Individualization of Medication Regimes Joseph S Bertino Jr., Pharm.D., FCCP Schenectady, NY USA Goals and Objectives To discuss pharmacogenetics and pharmacogenomics
More informationCYP1A2 polymorphism in Chinese patients with acute liver injury induced by Polygonum multiflorum
CYP1A2 polymorphism in Chinese patients with acute liver injury induced by Polygonum multiflorum K.F. Ma, X.G. Zhang and H.Y. Jia The First Affiliated Hospital, Zhejiang University, Hangzhou, China Corresponding
More informationOriginal Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk in a Chinese Han population
Int J Clin Exp Med 2014;7(12):5832-5836 www.ijcem.com /ISSN:1940-5901/IJCEM0002117 Original Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adherence, to bismuth quadruple therapy, 543 546 Adjuvant therapy, probiotics as, 567 569 Age factors, in gastric cancer, 611 612, 616 AID protein,
More informationSetting The setting was primary care. The economic study was carried out in Canada.
Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H-pylori-positive primary care patients with uninvestigated dyspepsia Chiba N, Van Zanten S J, Escobedo
More informationESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd
ESOPHAGEAL CANCER AND GERD Prof Salman Guraya FRCS, Masters MedEd Learning objectives Esophagus anatomy and physiology Esophageal cancer Causes, presentations of esophageal cancer Diagnosis and management
More informationGilles Jequier. Commercial Director Organobalance, a Novozymes Company
"Latest clinical Evidences showing that a proprietary Lactobacillus reuteri Strain can reduce the Symptoms associated with a Helicobacter pylori Infection" Gilles Jequier Commercial Director Organobalance,
More informationMANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) Routine endoscopic investigation of patients of any age, presenting with dyspepsia
More informationAlcohol-Related Liver Disease
Alcohol-Related Liver Disease Nonalcoholic Fatty Liver Disease (NAFLD) 1 Why is the liver important? Your liver is a vital organ that performs many essential functions. It filters out harmful substances
More informationSASKATCHEWAN REGISTERED NURSES ASSOCIATION
DEFINITION Reflux of gastric contents into the esophagus, which results in esophageal irritation or inflammation. IMMEDIATE CONSULTATION REQUIRED IN THE FOLLOWING SITUATIONS Dysphagia (solid food, progressive)
More informationDiagnostic test pepsinogen I and combination with tumor marker CEA in gastric cancer
IOP Conference Series: Earth and Environmental Science PAPER OPEN ACCESS Diagnostic test pepsinogen I and combination with tumor marker CEA in gastric cancer To cite this article: J Sembiring et al 2018
More informationReview article: pharmacology of esomeprazole and comparisons with omeprazole
Aliment Pharmacol Ther 2003; 17 (Suppl. 1): 5 9. Review article: pharmacology of esomeprazole and comparisons with omeprazole J. DENT Department of Gastroenterology, Hepatology and General Medicine, Royal
More informationAssociation between rs G<C gene polymorphism and susceptibility to pancreatic cancer in a Chinese population
Association between rs9904341 G
More informationFatal Gastrointestinal Perforations in sudden death cases in Last 10 years at UMMC- Malaysia
Fatal Gastrointestinal Perforations in sudden death cases in Last 10 years at UMMC- Malaysia Dr. OP Murty, Dr. Lye Yik Fan, Dr. Tan Ley Siang, Dr. Nurull Eddayu binti Hasbullah, Dr. Nurul Azwa binti Mohd
More informationGastric Ulcer / Gastritis
Gastric Ulcer / Gastritis Endoscopy Department Patient information leaflet You will only be given this leaflet if you have been diagnosed with gastritis and/or a gastric ulcer. The information below outlines
More informationAssociation between ADH2 /ALDH2 genetic polymorphism and habit of alcohol drinking and the susceptibility of rectal cancer
2007 10 14 19 CHIN J CANCER PREV TREA T,October 2007,Vol114 No119 1445 2 2 g 1, 1, 1, Takezaki Toshiro 2, 3, Tajima Kazuo 4, 1,5 1., 210009 2., 890-8544, 3., 500038 4., 464-8681, 5., 210029 Association
More informationRelationship of Helicobacter pylori Infection with Gastric Black Spots Shown by Endoscopy
doi: 10.2169/internalmedicine.1751-18 http://internmed.jp ORIGINAL ARTICLE Relationship of Helicobacter pylori Infection with Gastric Black Spots Shown by Endoscopy Kyoichi Adachi 1, Takumi Notsu 1, Tomoko
More informationVariability Due to Genetic Differences
1 Variability Due to Genetic Differences Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland 2 Objectives Understand how between individual variation may contribute to :» drug
More information